Breath Therapeutics GmbH

https://www.breath-therapeutics.com

Breath is a clinical stage biopharmaceutical company specializing in advanced and first-in-class inhalation therapies for severe respiratory diseases with high unmet medical need. For its clinical development, the Company is using new proprietary drug formulations optimized for inhaled administration with exclusively licensed, high performance nebulizers. Breath is focusing on integrated therapy solutions in the interaction between diagnostics, therapeutics and eHealth therapy monitoring. Breath´s lead development program BOSTON is addressing the treatment of BO with a proprietary formulation of liposomal cyclosporine for inhalation. With proceeds from a USD 46 million Series A financing by top-tier European investors Sofinnova, Gimv and Gilde Healthcare, the Company is currently initiating Phase 3 studies in the US and Europe. PARI Pharma, a worldwide leading nebulizer company, is a strategic development partner and licensor for the eFlow® nebulizer technology for Breath’s BOSTON program. Breath Therapeutics is Germany and US based with offices in Frankfurt, Munich and Boston. *

	Start	2016-09-14 established (s-off)
	Group	Zambon (Group)
	Predecessor	PARI Pharma GmbH
	Industry	respiratory drug delivery technology
	Person	Stegemann, Jens (Breath Therapeutics 201609– CEO)
	Person 2	Burger, Anne (MedVenture Partners 2002– Director + Breath Therapeutics 201609– CFO + Curetis 201007–2012 CFO)

	Region	München (Munich)
	Country	Germany
	Street	302 Landsberger Str.
	City	80687 München
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Breath Therapeutics B.V.. (7/11/18). "Press Release: Breath Therapeutics Appoints Noreen Roth Henig, M.D. as Chief Medical Officer". Munich, Frankfurt & Boston, MA.

		Record changed: 2023-12-30

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for Zambon (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)